scholarly journals Risks of different skin tumor combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population based cohorts: 1989 – 2009

2016 ◽  
Vol 22 (9) ◽  
Author(s):  
R.J.T van der Leest ◽  
L.M Hollestein ◽  
L Liu ◽  
T Nijsten ◽  
E de Vries
2017 ◽  
Vol 153 (2) ◽  
pp. 175 ◽  
Author(s):  
Padmini Subramaniam ◽  
Catherine M. Olsen ◽  
Bridie S. Thompson ◽  
David C. Whiteman ◽  
Rachel E. Neale ◽  
...  

2016 ◽  
Vol 22 (9) ◽  
Author(s):  
Jean Claude Dusingize ◽  
Catherine M Olsen ◽  
Nirmala Pandeya ◽  
Bridie Thompson ◽  
Rachel E Neale ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (14) ◽  
pp. 3402
Author(s):  
Eun Kyung Ko ◽  
Brian C. Capell

Recent evidence suggests that the disruption of gene expression by alterations in DNA, RNA, and histone methylation may be critical contributors to the pathogenesis of keratinocyte cancers (KCs), made up of basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), which collectively outnumber all other human cancers combined. While it is clear that methylation modifiers are frequently dysregulated in KCs, the underlying molecular and mechanistic changes are only beginning to be understood. Intriguingly, it has recently emerged that there is extensive cross-talk amongst these distinct methylation processes. Here, we summarize and synthesize the latest findings in this space and highlight how these discoveries may uncover novel therapeutic approaches for these ubiquitous cancers.


Sign in / Sign up

Export Citation Format

Share Document